Please ensure Javascript is enabled for purposes of website accessibility

Why Figs Stock Was Climbing Again Today

By Jeremy Bowman - Jun 22, 2021 at 5:40PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Bullish analyst chatter drove the stock higher for the second day in a row.

What happened

Shares of Figs (FIGS 6.88%) were moving higher again today as the healthcare apparel company gained for the second day in a row. Yesterday it received a slew of positive analyst ratings after the quiet period following its recent IPO ended.

The stock closed up 6.1% today after gaining 17% yesterday. Earlier in today's session, the stock was up as much as 16.7%.

A person in scrubs stepping out of a helicopter.

Image source: Figs.

So what

Figs IPO'ed quietly at the end of May, but the stock has steadily gained since then and is now worth more than double its $22 IPO price. Analysts and investors are both excited about the growing direct-to-consumer scrub seller that is disrupting the industry using an e-commerce model, proprietary technical fabrics, more functional designs, and a marketing model focused on millennials. 

Yesterday, several analysts weighed in with bullish ratings on the stock, touting Figs' disruptive potential, rapid growth, and ability to expand into non-health sectors. Research firm Guggenheim said the company should be able to exceed revenue of $1 billion by 2025, up from $263.1 million last year.  

KeyBanc analyst Edward Yruma, meanwhile, said its strong growth rate and wide EBITDA margins "make it one of the most compelling growth stories in our coverage."

Now what

Figs' valuation is getting stretched after its recent run; the stock now trades for a price-to-sales ratio of 23 and a price-to-earnings ratio of 125. However, after the company posted 172% revenue growth in its most recent quarter, it's clear why the stock warrants a premium valuation. That growth will moderate as Figs faces difficult comparisons over the rest of the year, and it's also likely to attract more competition over the coming years. 

Still, this growth stock is worth keeping an eye on after its impressive incursion into the healthcare apparel industry.

Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

FIGS, Inc. Stock Quote
FIGS, Inc.
$11.80 (6.88%) $0.76

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/08/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.